Skip to main content
Leonard Mazur

Leonard Mazur

Chief Executive Officer, Citius Pharmaceuticals
United States
Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with notable success in founding and building multiple healthcare companies and creating value and returns for investors throughout his five-decade career. Mr. Mazur was the co-founder and Chairman of Leonard-Meron Biosciences prior to its merger with Citius in March 2016. Previously, he was the co-founder and vice chairman of Akrimax Pharmaceuticals, which specialized in cardiovascular and general pharmaceutical products. Earlier, he co-founded and served as chief operating officer of Triax Pharmaceuticals, a specialty pharmaceutical producer of prescription dermatological drugs, and he was the founder and CEO of Genesis Pharmaceuticals, a dermatological products company. Mr. Mazur has extensive sales, marketing, and business development experience from previous tenures at Medicis Pharmaceutical Corporation, ICN Pharmaceuticals, Knoll Pharma (a division of BASF), and Cooper Laboratories. Mr. Mazur served in the U.S. Marine Corps Reserve and earned an an MBA from Temple University’s Fox School of Business. Mr. Mazur is a recipient of the Ellis Island Medal of Honor presented annually to those who immigrated to the United States during the Ellis Island era and have shown an outstanding commitment to serving the United States either professionally, culturally, or civically.

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.